Successful domino liver transplantation in maple syrup urine disease using a related living donor

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 6, 2014, Pages 522-526

  Feier, F H ^a   Miura, I K ^a   Fonseca, E A ^a   Porta, G ^a   Pugliese, R ^a   Porta, A ^a   Schwartz, I V D ^b,c   Margutti, A V B ^d   Camelo, Jr ^d   Yamaguchi, S N ^a   Taveira, A T ^e   Candido, H ^a   Benavides, M ^a   Danesi, V ^a   Guimaraes, T ^a   Kondo, M ^a   Chapchap, P ^a   Seda Neto, J ^a  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Universidade Estadual do Amazonas   (Brazil)

Author keywords

Branched chain ketoacid dehydrogenase mutation; Genotype; Heterozygous donor; Leucine; Metabolic disease

Indexed keywords

BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE; VALINE;

ARTICLE; BILE DUCT ATRESIA; BLOOD COMPATIBILITY; CASE REPORT; CHILD; CHOLANGITIS; COMA; DIET RESTRICTION; DYSPHAGIA; END STAGE LIVER DISEASE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETHARGY; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MAPLE SYRUP URINE DISEASE; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; PORTAL HYPERTENSION; PORTOENTEROSTOMY; PRESCHOOL CHILD; PSYCHOMOTOR DISORDER; RESPIRATORY TRACT INFECTION; SEIZURE; STOMACH TUBE; DNA SEQUENCE; GENETICS; MUTATION; PHENOTYPE; TREATMENT OUTCOME;

AMINO ACIDS, BRANCHED-CHAIN; CHILD, PRESCHOOL; GENOTYPE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MAPLE SYRUP URINE DISEASE; MUTATION; PHENOTYPE; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 84901684429     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20143830     Document Type: Article

References (20)

1. Nellis MM, Danner DJ. Gene preference in maple syrup urine disease. Am J Hum Genet 2001; 68: 232-237, doi: 10.1086/316950.
2. Strauss KA, Morton DH. Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 2003; 5: 329-341, doi: 10.1007/s11940-003-0039-3.
3. Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 2006; 6: 557-564, doi: 10.1111/j.1600-6143.2005. 01209.x.
4. Popescu I, Dima SO. Domino liver transplantation: how far can we push the paradigm? Liver Transpl 2012; 18: 22-28, doi: 10.1002/lt.22443.
5. Netter JC, Cossarizza G, Narcy C, Hubert P, Ogier H, Revillon Y, et al. [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment]. Arch Pediatr 1994; 1: 730-734.
6. Mazariegos GV, Morton DH, Sindhi R, Soltys K, Nayyar N, Bond G, et al. Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr 2012; 160: 116-121, doi: 10.1016/j.jpeds.2011.06.033.
7. Shellmer DA, DeVito DA, Dew MA, Noll RB, Feldman H, Strauss KA, et al. Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series. Pediatr Transplant 2011; 15: 58-64, doi: 10.1111/ j.1399-3046.2010.01411.x.
8. Chuang DT, Chuang JL, Wynn RM. Lessons from genetic disorders of branched-chain amino acid metabolism. J Nutr 2006; 136: 243S-249S.
9. Khanna A, Hart M, Nyhan WL, Hassanein T, Panyard-Davis J, Barshop BA. Domino liver transplantation in maple syrup urine disease. Liver Transpl 2006; 12: 876-882, doi: 10.1002/ lt.20744.
10. Morioka D, Kasahara M, Takada Y, Corrales JP, Yoshizawa A, Sakamoto S, et al. Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 2005; 5: 2754-2763, doi: 10.1111/j.1600-6143. 2005.01084.x.
11. Flaschker N, Feyen O, Fend S, Simon E, Schadewaldt P, Wendel U. Description of the mutations in 15 subjects with variant forms of maple syrup urine disease. J Inherit Metab Dis 2007; 30: 903-909, doi: 10.1007/s10545-007-0579-x.
12. Zhang B, Edenberg HJ, Crabb DW, Harris RA. Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease. J Clin Invest 1989; 83: 1425-1429, doi: 10.1172/JCI114033.
13. McConnell BB, Burkholder B, Danner DJ. Two new mutations in the human E1 beta subunit of branched chain alpha-ketoacid dehydrogenase associated with maple syrup urine disease. Biochim Biophys Acta 1997; 1361: 263-271, doi: 10.1016/S0925-4439(97)00046-X.
14. Chuang DT, Ku LS, Kerr DS, Cox RP. Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures. Am J Hum Genet 1982; 34: 416-424.
15. Zaleski LA, Dancis J, Cox RP, Hutzler J, Zaleski WA, Hill A. Variant maple syrup urine disease in mother and daughter. Can Med Assoc J 1973; 109: 299-300.
16. Tsuruta M, Mitsubuchi H, Mardy S, Miura Y, Hayashida Y, Kinugasa A, et al. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex. J Hum Genet 1998; 43: 91-100, doi: 10.1007/s100380050047.
17. Henneke M, Flaschker N, Helbling C, Muller M, Schadewaldt P, Gartner J, et al. Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease. Hum Mutat 2003; 22: 417, doi: 10.1002/humu.9187.
18. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 2009; 25: 2744-2750, doi: 10.1093/bioinformatics/btp528.
19. Neto JS, Carone E, Pugliese RP, Fonseca EA, Porta G, Miura I, et al. Modified pediatric end-stage liver disease scoring system and pediatric liver transplantation in Brazil. Liver Transpl 2010; 16: 426-430.
20. Morioka D, Takada Y, Kasahara M, Ito T, Uryuhara K, Ogawa K, et al. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation 2005; 80: 623-628, doi: 10.1097/01.tp.0000167995.46778.72.